Almost every new mother will feel tearful, overwhelmed, or emotionally fragile in the first days after giving birth. This is commonly referred to as the baby blues, and it is so prevalent that many clinicians consider it a normal physiological response to the hormonal upheaval of delivery. Postpartum depression is something different entirely. The distinction matters because one resolves on its own; the other does not.
Baby blues — what they are and how long they last
Baby blues affect up to 80% of women following childbirth.1 Symptoms typically appear two to three days after delivery and include mood swings, tearfulness, irritability, difficulty sleeping, and feeling overwhelmed. Crucially, these symptoms are self-limiting. They peak around day four or five and resolve without treatment by day ten to fourteen.2
Baby blues do not impair a mother's ability to function or care for her infant. They are uncomfortable and sometimes distressing, but they do not require clinical intervention. The hormonal mechanism is well established: oestrogen and progesterone levels drop dramatically within hours of placental delivery, and this sudden withdrawal is thought to trigger the transient mood disturbance.3
Postpartum depression — a clinical condition
Postpartum depression (PPD) is a diagnosable mood disorder. The DSM-5 classifies it under major depressive disorder with peripartum onset specifier, recognising that symptoms can begin during pregnancy or within the first four weeks postpartum.4 ACOG extends this window to the first twelve months after delivery, reflecting clinical reality more accurately.5
PPD affects approximately one in seven perinatal women globally.6 Prevalence estimates vary by population and measurement method, ranging from 10 to 20% in high-income countries when measured by self-report instruments such as the Edinburgh Postnatal Depression Scale (EPDS).7 A 2024 systematic review found the mean global prevalence of postnatal depression to be approximately 27.6% when all study populations were included, with higher rates among vulnerable groups.8
Unlike the baby blues, PPD symptoms persist beyond two weeks and cause functional impairment. They include sustained low mood, loss of interest or pleasure, significant appetite or sleep changes (beyond normal newborn-related disruption), fatigue, feelings of worthlessness or guilt, difficulty concentrating, and in severe cases, recurrent thoughts of death or self-harm.4
Key differences at a glance
Timeline: Baby blues appear within the first few days and resolve by two weeks. PPD persists beyond two weeks and can develop at any point in the first year.
Severity: Baby blues involve mood lability but not functional impairment. PPD interferes with daily activities, maternal caregiving, and relationships.
Treatment: Baby blues require reassurance, rest, and social support. PPD typically requires structured intervention — psychotherapy (cognitive behavioural therapy or interpersonal therapy), pharmacotherapy, or both.9
Screening and detection
In June 2023, ACOG published its first Clinical Practice Guidelines for perinatal mental health, recommending that all pregnant and postpartum individuals be screened for depression and anxiety using standardised, validated instruments at the initial prenatal visit, later in pregnancy, and at postpartum visits.5 NICE CG192 similarly recommends that healthcare professionals ask about emotional wellbeing at every postnatal contact.10
The Edinburgh Postnatal Depression Scale (EPDS) remains the most widely used screening tool globally. It is a ten-item self-report questionnaire validated specifically for the perinatal population. A score of 10 or above on the EPDS typically indicates possible depression warranting further assessment.11 The WHO 2022 recommendations on postnatal care endorsed routine screening for maternal depression and anxiety during the postnatal period for the first time at a global policy level.12
A 2025 meta-analysis examining comorbid anxiety and depression in the perinatal period, drawing on 122 studies and over 560,000 women across 43 countries, found that approximately 9% of postpartum women experienced both conditions simultaneously — reinforcing the need for screening that captures anxiety alongside depression.13
Risk factors
Established risk factors for PPD include a personal or family history of depression, depression or anxiety during pregnancy, stressful life events during pregnancy, lack of social support, intimate partner violence, and obstetric complications.5 Baby blues themselves are a recognised predictor: a 2024 cohort study found that postpartum blues approximately doubled the risk of early-onset PPD, with each additional risk factor increasing the likelihood of baby blues by 31%.14
When to seek help
If symptoms of low mood, anxiety, or tearfulness have not resolved by two weeks postpartum, or if they are worsening rather than improving, this warrants professional assessment. Any thoughts of self-harm, any inability to care for the infant, or any symptoms of psychosis (hallucinations, delusions, severe confusion) require immediate clinical evaluation.5
PPD is treatable. Early identification and appropriate intervention significantly improve outcomes for both the mother and the infant. The SHORE planner's Module 4 (Mental Health & PMADs) provides validated screening tools and structured tracking to support early recognition.
